Accenture (ACN) Competitors

$159.68 -10.09 (-5.94%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$160.50 +0.82 (+0.51%)

As of 05:20 AM Eastern

ACN vs. CAR, CCRN, CRAI, CTSH, and NVDA

Should you buy Accenture stock or one of its competitors? MarketBeat compares Accenture with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Accenture include Avis Budget Group (CAR), Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Cognizant Technology Solutions (CTSH), and NVIDIA (NVDA).

How does Accenture compare to Avis Budget Group?

Accenture (NYSE:ACN) and Avis Budget Group (NASDAQ:CAR) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Accenture presently has a consensus price target of $274.50, suggesting a potential upside of 71.90%. Avis Budget Group has a consensus price target of $125.00, suggesting a potential downside of 16.02%. Given Accenture's stronger consensus rating and higher possible upside, research analysts plainly believe Accenture is more favorable than Avis Budget Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accenture	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63
Avis Budget Group	5 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Accenture had 21 more articles in the media than Avis Budget Group. MarketBeat recorded 31 mentions for Accenture and 10 mentions for Avis Budget Group. Accenture's average media sentiment score of 1.09 beat Avis Budget Group's score of 0.78 indicating that Accenture is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accenture	22 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avis Budget Group	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Accenture has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Avis Budget Group has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market.

75.1% of Accenture shares are owned by institutional investors. Comparatively, 96.3% of Avis Budget Group shares are owned by institutional investors. 0.0% of Accenture shares are owned by insiders. Comparatively, 50.5% of Avis Budget Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Accenture has a net margin of 10.61% compared to Avis Budget Group's net margin of -5.68%. Accenture's return on equity of 26.33% beat Avis Budget Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accenture	10.61%	26.33%	12.94%
Avis Budget Group	-5.68%	N/A	-0.47%

Accenture has higher revenue and earnings than Avis Budget Group. Avis Budget Group is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accenture	$69.67B	1.53	$7.68B	$12.21	13.08
Avis Budget Group	$11.86B	0.44	-$889M	-$19.05	N/A

Summary

Accenture beats Avis Budget Group on 13 of the 16 factors compared between the two stocks.

How does Accenture compare to Cross Country Healthcare?

Accenture (NYSE:ACN) and Cross Country Healthcare (NASDAQ:CCRN) are related companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Accenture presently has a consensus price target of $274.50, suggesting a potential upside of 71.90%. Cross Country Healthcare has a consensus price target of $12.72, suggesting a potential downside of 3.05%. Given Accenture's stronger consensus rating and higher probable upside, analysts plainly believe Accenture is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accenture	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market.

In the previous week, Accenture had 9 more articles in the media than Cross Country Healthcare. MarketBeat recorded 31 mentions for Accenture and 22 mentions for Cross Country Healthcare. Accenture's average media sentiment score of 1.09 beat Cross Country Healthcare's score of -0.03 indicating that Accenture is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accenture	22 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	1 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral

Accenture has a net margin of 10.61% compared to Cross Country Healthcare's net margin of -9.84%. Accenture's return on equity of 26.33% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accenture	10.61%	26.33%	12.94%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

75.1% of Accenture shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 0.0% of Accenture shares are held by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Accenture has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accenture	$69.67B	1.53	$7.68B	$12.21	13.08
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

Summary

Accenture beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Accenture compare to Charles River Associates?

Charles River Associates (NASDAQ:CRAI) and Accenture (NYSE:ACN) are related companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

84.1% of Charles River Associates shares are owned by institutional investors. Comparatively, 75.1% of Accenture shares are owned by institutional investors. 4.5% of Charles River Associates shares are owned by insiders. Comparatively, 0.0% of Accenture shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Charles River Associates currently has a consensus price target of $245.00, indicating a potential upside of 76.22%. Accenture has a consensus price target of $274.50, indicating a potential upside of 71.90%. Given Charles River Associates' higher probable upside, research analysts plainly believe Charles River Associates is more favorable than Accenture.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charles River Associates	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Accenture	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63

In the previous week, Accenture had 14 more articles in the media than Charles River Associates. MarketBeat recorded 31 mentions for Accenture and 17 mentions for Charles River Associates. Accenture's average media sentiment score of 1.09 beat Charles River Associates' score of 0.08 indicating that Accenture is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Charles River Associates	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Accenture	22 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Accenture has higher revenue and earnings than Charles River Associates. Accenture is trading at a lower price-to-earnings ratio than Charles River Associates, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charles River Associates	$751.58M	1.19	$54.78M	$7.20	19.31
Accenture	$69.67B	1.53	$7.68B	$12.21	13.08

Charles River Associates has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Accenture has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

Accenture has a net margin of 10.61% compared to Charles River Associates' net margin of 6.22%. Accenture's return on equity of 26.33% beat Charles River Associates' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charles River Associates	6.22%	26.02%	8.35%
Accenture	10.61%	26.33%	12.94%

Charles River Associates pays an annual dividend of $2.28 per share and has a dividend yield of 1.6%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 4.1%. Charles River Associates pays out 31.7% of its earnings in the form of a dividend. Accenture pays out 53.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Charles River Associates has increased its dividend for 7 consecutive years and Accenture has increased its dividend for 20 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Accenture beats Charles River Associates on 14 of the 19 factors compared between the two stocks.

How does Accenture compare to Cognizant Technology Solutions?

Cognizant Technology Solutions (NASDAQ:CTSH) and Accenture (NYSE:ACN) are both large-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.9%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 4.1%. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Accenture pays out 53.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognizant Technology Solutions has raised its dividend for 6 consecutive years and Accenture has raised its dividend for 20 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Accenture had 14 more articles in the media than Cognizant Technology Solutions. MarketBeat recorded 31 mentions for Accenture and 17 mentions for Cognizant Technology Solutions. Accenture's average media sentiment score of 1.09 beat Cognizant Technology Solutions' score of 0.51 indicating that Accenture is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cognizant Technology Solutions	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive
Accenture	22 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cognizant Technology Solutions has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

92.4% of Cognizant Technology Solutions shares are owned by institutional investors. Comparatively, 75.1% of Accenture shares are owned by institutional investors. 0.4% of Cognizant Technology Solutions shares are owned by company insiders. Comparatively, 0.0% of Accenture shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cognizant Technology Solutions currently has a consensus price target of $73.33, indicating a potential upside of 59.52%. Accenture has a consensus price target of $274.50, indicating a potential upside of 71.90%. Given Accenture's stronger consensus rating and higher possible upside, analysts clearly believe Accenture is more favorable than Cognizant Technology Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cognizant Technology Solutions	0 Sell rating(s)	12 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.45
Accenture	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63

Accenture has higher revenue and earnings than Cognizant Technology Solutions. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cognizant Technology Solutions	$21.11B	1.03	$2.23B	$4.60	9.99
Accenture	$69.67B	1.53	$7.68B	$12.21	13.08

Accenture has a net margin of 10.61% compared to Cognizant Technology Solutions' net margin of 10.41%. Accenture's return on equity of 26.33% beat Cognizant Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cognizant Technology Solutions	10.41%	17.50%	12.94%
Accenture	10.61%	26.33%	12.94%

Summary

Accenture beats Cognizant Technology Solutions on 15 of the 18 factors compared between the two stocks.

How does Accenture compare to NVIDIA?

NVIDIA (NASDAQ:NVDA) and Accenture (NYSE:ACN) are both large-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

NVIDIA has higher revenue and earnings than Accenture. Accenture is trading at a lower price-to-earnings ratio than NVIDIA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NVIDIA	$215.94B	25.41	$120.07B	$4.90	46.09
Accenture	$69.67B	1.53	$7.68B	$12.21	13.08

In the previous week, NVIDIA had 333 more articles in the media than Accenture. MarketBeat recorded 364 mentions for NVIDIA and 31 mentions for Accenture. Accenture's average media sentiment score of 1.09 beat NVIDIA's score of 0.79 indicating that Accenture is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NVIDIA	202 Very Positive mention(s)	48 Positive mention(s)	72 Neutral mention(s)	30 Negative mention(s)	8 Very Negative mention(s)	Positive
Accenture	22 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NVIDIA currently has a consensus price target of $277.32, indicating a potential upside of 22.80%. Accenture has a consensus price target of $274.50, indicating a potential upside of 71.90%. Given Accenture's higher possible upside, analysts clearly believe Accenture is more favorable than NVIDIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NVIDIA	0 Sell rating(s)	2 Hold rating(s)	48 Buy rating(s)	4 Strong Buy rating(s)	3.04
Accenture	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63

NVIDIA has a net margin of 55.60% compared to Accenture's net margin of 10.61%. NVIDIA's return on equity of 97.37% beat Accenture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NVIDIA	55.60%	97.37%	70.68%
Accenture	10.61%	26.33%	12.94%

NVIDIA has a beta of 2.25, meaning that its stock price is 125% more volatile than the broader market. Comparatively, Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

65.3% of NVIDIA shares are owned by institutional investors. Comparatively, 75.1% of Accenture shares are owned by institutional investors. 4.2% of NVIDIA shares are owned by company insiders. Comparatively, 0.0% of Accenture shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

NVIDIA pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 4.1%. NVIDIA pays out 0.8% of its earnings in the form of a dividend. Accenture pays out 53.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. NVIDIA has raised its dividend for 1 consecutive years and Accenture has raised its dividend for 20 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

NVIDIA beats Accenture on 14 of the 20 factors compared between the two stocks.

Get Accenture News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACN vs. The Competition

Export

Metric	Accenture	IT Services Industry	Computer Sector	NYSE Exchange
Market Cap	$112.97B	$12.73B	$38.55B	$22.96B
Dividend Yield	3.84%	2.51%	3.19%	4.07%
P/E Ratio	13.08	44.79	164.46	28.29
Price / Sales	1.53	6.30	626.69	24.48
Price / Cash	10.39	24.79	47.82	25.11
Price / Book	3.26	3.44	9.47	4.73
Net Income	$7.68B	$544.53M	$1.03B	$1.07B
7 Day Performance	-11.48%	-7.48%	-0.03%	-1.11%
1 Month Performance	-16.12%	-2.73%	9.13%	1.36%
1 Year Performance	-50.26%	-15.05%	163.91%	24.41%

Accenture Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACN Accenture	4.9398 of 5 stars	$159.68 -5.9%	$274.50 +71.9%	-50.5%	$112.97B	$69.67B	13.08	779,000	Positive News Options Volume High Trading Volume
CAR Avis Budget Group	3.3819 of 5 stars	$168.30 -9.3%	$125.00 -25.7%	+40.0%	$5.95B	$11.65B	N/A	25,000
CCRN Cross Country Healthcare	2.203 of 5 stars	$10.31 +0.8%	$12.53 +21.6%	-5.9%	$331.97M	$1.05B	N/A	6,784	Earnings Report Analyst Forecast
CRAI Charles River Associates	4.6764 of 5 stars	$163.22 +0.9%	$245.00 +50.1%	-26.8%	$1.05B	$751.58M	20.08	940	Earnings Report Analyst Downgrade Analyst Revision
CTSH Cognizant Technology Solutions	4.7921 of 5 stars	$51.86 -1.1%	$76.40 +47.3%	-43.4%	$24.80B	$21.11B	11.27	351,600	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ACN) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accenture (ACN) Competitors

ACN vs. CAR, CCRN, CRAI, CTSH, and NVDA

How does Accenture compare to Avis Budget Group?

Summary

How does Accenture compare to Cross Country Healthcare?

Summary

How does Accenture compare to Charles River Associates?

Summary

How does Accenture compare to Cognizant Technology Solutions?

Summary

How does Accenture compare to NVIDIA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACN vs. The Competition

Accenture Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Accenture (ACN) Competitors

ACN vs. CAR, CCRN, CRAI, CTSH, and NVDA

How does Accenture compare to Avis Budget Group?

Do analysts prefer ACN or CAR?

Does the media refer more to ACN or CAR?

Which has more risk & volatility, ACN or CAR?

Do insiders and institutionals hold more shares of ACN or CAR?

Is ACN or CAR more profitable?

Which has higher earnings & valuation, ACN or CAR?

Summary

How does Accenture compare to Cross Country Healthcare?

Do analysts prefer ACN or CCRN?

Which has more risk and volatility, ACN or CCRN?

Does the media prefer ACN or CCRN?

Is ACN or CCRN more profitable?

Do institutionals and insiders hold more shares of ACN or CCRN?

Which has better valuation and earnings, ACN or CCRN?

Summary

How does Accenture compare to Charles River Associates?

Do institutionals and insiders hold more shares of CRAI or ACN?

Do analysts recommend CRAI or ACN?

Does the media prefer CRAI or ACN?

Which has stronger earnings & valuation, CRAI or ACN?

Which has more risk & volatility, CRAI or ACN?

Is CRAI or ACN more profitable?

Is CRAI or ACN a better dividend stock?

Summary

How does Accenture compare to Cognizant Technology Solutions?

Is CTSH or ACN a better dividend stock?

Does the media favor CTSH or ACN?

Which has more volatility & risk, CTSH or ACN?

Do institutionals & insiders hold more shares of CTSH or ACN?

Do analysts prefer CTSH or ACN?

Which has higher earnings and valuation, CTSH or ACN?

Is CTSH or ACN more profitable?

Summary

How does Accenture compare to NVIDIA?

Which has higher earnings and valuation, NVDA or ACN?

Does the media favor NVDA or ACN?

Do analysts prefer NVDA or ACN?

Is NVDA or ACN more profitable?

Which has more volatility & risk, NVDA or ACN?

Do institutionals & insiders hold more shares of NVDA or ACN?

Is NVDA or ACN a better dividend stock?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACN vs. The Competition

Accenture Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools